MCK
$941.89
McKesson Corporation provides healthcare services in the United States and internationally.
Intraday
Recent News
Top Stock Reports for GE Aerospace, Shell & McKesson
GE Aerospace gains on strong engine demand and defense tailwinds, while Shell and McKesson navigate mixed performance and strategic shifts.
Cencora CFO announces retirement
James Cleary will step down from the post on June 30, but stay on as an adviser to the company through the end of the year. He’s the second finance chief of a drug distributor to announce their retirement this month.
McKesson (MCK) Upgraded to Buy: Here's Why
McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
3 Stocks That Could Be Next to Announce a Stock Split
Stock splits often follow strong growth. Here are three high-priced stocks that could be candidates for a stock split in 2026
How McKesson’s CFO Transition and Neulasta Biosimilar Push At McKesson (MCK) Has Changed Its Investment Story
Earlier this month, McKesson Corporation announced that long‑time Chief Financial Officer Britt Vitalone will retire as CFO on May 28, 2026, with incoming Executive Vice President Kenny Cheung set to assume the finance leadership role from May 29, 2026, while Vitalone remains as a strategic advisor through the planned separation of Medical Surgical Solutions. At the same time, McKesson’s progress in securing a new National Drug Code for a biosimilar version of Neulasta highlights how finance...